Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTangible Book ValueTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NewGenIvf (NIVF) Payables (2022 - 2024)

Historic Payables for NewGenIvf (NIVF) over the last 3 years, with Q4 2024 value amounting to $500.0 billion.

  • NewGenIvf's Payables rose 20694294485.44% to $500.0 billion in Q4 2024 from the same period last year, while for Dec 2024 it was $500.0 billion, marking a year-over-year increase of 20694294485.44%. This contributed to the annual value of $500.0 billion for FY2024, which is 20694294485.44% up from last year.
  • Latest data reveals that NewGenIvf reported Payables of $500.0 billion as of Q4 2024, which was up 20694294485.44% from $241613.0 recorded in Q4 2023.
  • Over the past 5 years, NewGenIvf's Payables peaked at $500.0 billion during Q4 2024, and registered a low of $241613.0 during Q4 2023.
  • In the last 3 years, NewGenIvf's Payables had a median value of $289777.0 in 2022 and averaged $166.7 billion.
  • As far as peak fluctuations go, NewGenIvf's Payables tumbled by 1662.11% in 2023, and later skyrocketed by 20694294485.44% in 2024.
  • Over the past 3 years, NewGenIvf's Payables (Quarter) stood at $289777.0 in 2022, then fell by 16.62% to $241613.0 in 2023, then surged by 206942944.85% to $500.0 billion in 2024.
  • Its Payables was $500.0 billion in Q4 2024, compared to $241613.0 in Q4 2023 and $289777.0 in Q4 2022.